Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
American Journal of Hematology|January 25, 2024
Adoptive cellular therapy after hematopoietic stem cell transplantationPongthep Vittayawacharin, Piyanuch Kongtim, Yaya Chu, et al.Best Practice & Research. Clinical Haematology|March 12, 2023
Cellular and humoral immunotherapy in children, adolescents and young adults with non-Hodgkin lymphomaYaya Chu, Aliza Gardenswartz, Caroline Diorio, et al.Cytotherapy|May 27, 2014
Upregulation of NKG2D ligands in acute lymphoblastic leukemia and non-Hodgkin lymphoma cells by romidepsin and enhanced in vitro and in vivo natural killer cell cytotoxicityPrakash Satwani, Sejal Bavishi, Aniket Saha, et al.Cancer Immunology Research|December 11, 2014
Targeting CD20+ Aggressive B-cell Non-Hodgkin Lymphoma by Anti-CD20 CAR mRNA-Modified Expanded Natural Killer Cells In Vitro and in NSG MiceYaya Chu, Jessica Hochberg, Ashlin Yahr, et al.International Journal of Biological Macromolecules|February 24, 2025
A novel starch from Trichosanthes kirilowii roots: A comparison of its composition, structure and physicochemical properties with conventional root starchChuanzhi Ha, Tao Sheng, Yujie Wu, et al.Experimental Hematology|October 22, 2016
Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapyJanet Ayello, Jessica Hochberg, Allyson Flower, et al.Journal for Immunotherapy of Cancer|July 10, 2021
Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2+ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG miceYaya Chu, Gaurav Nayyar, Susiyan Jiang, et al.Innate Immunity|May 10, 2019
Immunophenotypic, cytotoxic, proteomic and genomic characterization of human cord blood vs. peripheral blood CD56Dim NK cellsEvan Shereck, Nancy S Day, Aradhana Awasthi, et al.Journal for Immunotherapy of Cancer|October 28, 2020
Novel cytokine-antibody fusion protein, N-820, to enhance the functions of ex vivo expanded natural killer cells against Burkitt lymphomaYaya Chu, Gaurav Nayyar, Nang Kham Su, et al.Seminars in Hematology|December 1, 2020
Genetic and epigenetic modification of human primary NK cells for enhanced antitumor activityMeisam Naeimi Kararoudi, Brian P Tullius, Nitin Chakravarti, et al.Pageof 3